Clinical Trial Update: Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating prophylactic cranial irradiation in patients with HER2-positive metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Alberta Health services | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED